The global Montelukast Sodium Granules market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Montelukast Sodium Granules is a drug used for the prevention and long-term treatment of asthma and relief of allergic rhinitis symptoms. Its main ingredient is montelukast sodium, which is a leukotriene receptor antagonist. Leukotrienes are chemicals that play a role in allergic reactions and inflammation. Montelukast helps control asthma symptoms by blocking leukotriene receptors, reducing inflammation and airway constriction.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Montelukast Sodium Granules leading manufacturers including Organon LLC, Novartis, Dong-A ST, Dr. Reddy's Laboratories, Pfizer, Luye Pharma Group, Hengrui Medicine, Hybio Pharmaceutical, Teva Pharmaceutical Industries, Mylan Pharmaceuticals, etc., dominate supply; the top five capture approximately % of global revenue, with Organon LLC leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Montelukast Sodium Granules market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Montelukast Sodium Granules Market Report

Report Metric	Details
Report Name	Montelukast Sodium Granules Market
Segment by Type	5mg 10mg
Segment by Application	Hospital Clinic Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Organon LLC, Novartis, Dong-A ST, Dr. Reddy's Laboratories, Pfizer, Luye Pharma Group, Hengrui Medicine, Hybio Pharmaceutical, Teva Pharmaceutical Industries, Mylan Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Montelukast Sodium Granules study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Montelukast Sodium Granules Market report?

Ans: The main players in the Montelukast Sodium Granules Market are Organon LLC, Novartis, Dong-A ST, Dr. Reddy's Laboratories, Pfizer, Luye Pharma Group, Hengrui Medicine, Hybio Pharmaceutical, Teva Pharmaceutical Industries, Mylan Pharmaceuticals

What are the Application segmentation covered in the Montelukast Sodium Granules Market report?

Ans: The Applications covered in the Montelukast Sodium Granules Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Montelukast Sodium Granules Market report?

Ans: The Types covered in the Montelukast Sodium Granules Market report are 5mg, 10mg

1 Study Coverage

1.1 Introduction to Montelukast Sodium Granules: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Montelukast Sodium Granules Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 5mg

1.2.3 10mg

1.3 Market Segmentation by Application

1.3.1 Global Montelukast Sodium Granules Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Montelukast Sodium Granules Revenue Estimates and Forecasts 2020-2031

2.2 Global Montelukast Sodium Granules Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Montelukast Sodium Granules Sales Estimates and Forecasts 2020-2031

2.4 Global Montelukast Sodium Granules Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Montelukast Sodium Granules Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Montelukast Sodium Granules Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 5mg Market Size by Manufacturers

3.5.2 10mg Market Size by Manufacturers

3.6 Global Montelukast Sodium Granules Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Montelukast Sodium Granules Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Montelukast Sodium Granules Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Montelukast Sodium Granules Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Montelukast Sodium Granules Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Montelukast Sodium Granules Sales and Revenue by Type (2020-2031)

6.4 North America Montelukast Sodium Granules Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Montelukast Sodium Granules Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Montelukast Sodium Granules Sales and Revenue by Type (2020-2031)

7.4 Europe Montelukast Sodium Granules Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Montelukast Sodium Granules Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Montelukast Sodium Granules Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Montelukast Sodium Granules Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Montelukast Sodium Granules Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Montelukast Sodium Granules Sales and Revenue by Type (2020-2031)

9.4 Central and South America Montelukast Sodium Granules Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Montelukast Sodium Granules Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Montelukast Sodium Granules Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Montelukast Sodium Granules Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Montelukast Sodium Granules Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Organon LLC

11.1.1 Organon LLC Corporation Information

11.1.2 Organon LLC Business Overview

11.1.3 Organon LLC Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.1.4 Organon LLC Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Organon LLC Montelukast Sodium Granules Sales by Product in 2024

11.1.6 Organon LLC Montelukast Sodium Granules Sales by Application in 2024

11.1.7 Organon LLC Montelukast Sodium Granules Sales by Geographic Area in 2024

11.1.8 Organon LLC Montelukast Sodium Granules SWOT Analysis

11.1.9 Organon LLC Recent Developments

11.2 Novartis

11.2.1 Novartis Corporation Information

11.2.2 Novartis Business Overview

11.2.3 Novartis Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.2.4 Novartis Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Novartis Montelukast Sodium Granules Sales by Product in 2024

11.2.6 Novartis Montelukast Sodium Granules Sales by Application in 2024

11.2.7 Novartis Montelukast Sodium Granules Sales by Geographic Area in 2024

11.2.8 Novartis Montelukast Sodium Granules SWOT Analysis

11.2.9 Novartis Recent Developments

11.3 Dong-A ST

11.3.1 Dong-A ST Corporation Information

11.3.2 Dong-A ST Business Overview

11.3.3 Dong-A ST Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.3.4 Dong-A ST Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Dong-A ST Montelukast Sodium Granules Sales by Product in 2024

11.3.6 Dong-A ST Montelukast Sodium Granules Sales by Application in 2024

11.3.7 Dong-A ST Montelukast Sodium Granules Sales by Geographic Area in 2024

11.3.8 Dong-A ST Montelukast Sodium Granules SWOT Analysis

11.3.9 Dong-A ST Recent Developments

11.4 Dr. Reddy's Laboratories

11.4.1 Dr. Reddy's Laboratories Corporation Information

11.4.2 Dr. Reddy's Laboratories Business Overview

11.4.3 Dr. Reddy's Laboratories Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.4.4 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales by Product in 2024

11.4.6 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales by Application in 2024

11.4.7 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales by Geographic Area in 2024

11.4.8 Dr. Reddy's Laboratories Montelukast Sodium Granules SWOT Analysis

11.4.9 Dr. Reddy's Laboratories Recent Developments

11.5 Pfizer

11.5.1 Pfizer Corporation Information

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.5.4 Pfizer Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Pfizer Montelukast Sodium Granules Sales by Product in 2024

11.5.6 Pfizer Montelukast Sodium Granules Sales by Application in 2024

11.5.7 Pfizer Montelukast Sodium Granules Sales by Geographic Area in 2024

11.5.8 Pfizer Montelukast Sodium Granules SWOT Analysis

11.5.9 Pfizer Recent Developments

11.6 Luye Pharma Group

11.6.1 Luye Pharma Group Corporation Information

11.6.2 Luye Pharma Group Business Overview

11.6.3 Luye Pharma Group Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.6.4 Luye Pharma Group Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Luye Pharma Group Recent Developments

11.7 Hengrui Medicine

11.7.1 Hengrui Medicine Corporation Information

11.7.2 Hengrui Medicine Business Overview

11.7.3 Hengrui Medicine Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.7.4 Hengrui Medicine Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Hengrui Medicine Recent Developments

11.8 Hybio Pharmaceutical

11.8.1 Hybio Pharmaceutical Corporation Information

11.8.2 Hybio Pharmaceutical Business Overview

11.8.3 Hybio Pharmaceutical Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.8.4 Hybio Pharmaceutical Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Hybio Pharmaceutical Recent Developments

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Corporation Information

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.9.4 Teva Pharmaceutical Industries Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Teva Pharmaceutical Industries Recent Developments

11.10 Mylan Pharmaceuticals

11.10.1 Mylan Pharmaceuticals Corporation Information

11.10.2 Mylan Pharmaceuticals Business Overview

11.10.3 Mylan Pharmaceuticals Montelukast Sodium Granules Product Models, Descriptions and Specifications

11.10.4 Mylan Pharmaceuticals Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Mylan Pharmaceuticals Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Montelukast Sodium Granules Industry Chain

12.2 Montelukast Sodium Granules Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Montelukast Sodium Granules Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Montelukast Sodium Granules Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Montelukast Sodium Granules Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Montelukast Sodium Granules Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Organon

Novartis

Dong-A ST

Dr. Reddy’s Laboratories

Teva Pharmaceutical Industries

Mylan Pharmaceuticals

List of Tables

Table 1. Global Montelukast Sodium Granules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Montelukast Sodium Granules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Montelukast Sodium Granules Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Montelukast Sodium Granules Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Montelukast Sodium Granules Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 7. Global Montelukast Sodium Granules Sales by Region (2020-2025) & (kg)

Table 8. Global Montelukast Sodium Granules Sales by Region (2026-2031) & (kg)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Montelukast Sodium Granules Sales by Manufacturers (2020-2025) & (kg)

Table 11. Global Montelukast Sodium Granules Sales Share by Manufacturers (2020-2025)

Table 12. Global Montelukast Sodium Granules Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Montelukast Sodium Granules Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Montelukast Sodium Granules by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Sodium Granules as of 2024)

Table 16. Global Montelukast Sodium Granules Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Montelukast Sodium Granules Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)

Table 18. Key Manufacturers Montelukast Sodium Granules Manufacturing Base and Headquarters

Table 19. Global Montelukast Sodium Granules Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Montelukast Sodium Granules Sales by Type (2020-2025) & (kg)

Table 23. Global Montelukast Sodium Granules Sales by Type (2026-2031) & (kg)

Table 24. Global Montelukast Sodium Granules Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Montelukast Sodium Granules Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Montelukast Sodium Granules ASP by Type (2020-2031) & (US$/kg)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Montelukast Sodium Granules Sales by Application (2020-2025) & (kg)

Table 29. Global Montelukast Sodium Granules Sales by Application (2026-2031) & (kg)

Table 30. Montelukast Sodium Granules High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Montelukast Sodium Granules Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Montelukast Sodium Granules Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Montelukast Sodium Granules ASP by Application (2020-2031) & (US$/kg)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Montelukast Sodium Granules Growth Accelerators and Market Barriers

Table 37. North America Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Montelukast Sodium Granules Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Montelukast Sodium Granules Growth Accelerators and Market Barriers

Table 40. Europe Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Montelukast Sodium Granules Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Montelukast Sodium Granules Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Montelukast Sodium Granules Growth Accelerators and Market Barriers

Table 45. Southeast Asia Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Montelukast Sodium Granules Investment Opportunities and Key Challenges

Table 47. Central and South America Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Montelukast Sodium Granules Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Organon LLC Corporation Information

Table 51. Organon LLC Description and Major Businesses

Table 52. Organon LLC Product Models, Descriptions and Specifications

Table 53. Organon LLC Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 54. Organon LLC Sales Value Proportion by Product in 2024

Table 55. Organon LLC Sales Value Proportion by Application in 2024

Table 56. Organon LLC Sales Value Proportion by Geographic Area in 2024

Table 57. Organon LLC Montelukast Sodium Granules SWOT Analysis

Table 58. Organon LLC Recent Developments

Table 59. Novartis Corporation Information

Table 60. Novartis Description and Major Businesses

Table 61. Novartis Product Models, Descriptions and Specifications

Table 62. Novartis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 63. Novartis Sales Value Proportion by Product in 2024

Table 64. Novartis Sales Value Proportion by Application in 2024

Table 65. Novartis Sales Value Proportion by Geographic Area in 2024

Table 66. Novartis Montelukast Sodium Granules SWOT Analysis

Table 67. Novartis Recent Developments

Table 68. Dong-A ST Corporation Information

Table 69. Dong-A ST Description and Major Businesses

Table 70. Dong-A ST Product Models, Descriptions and Specifications

Table 71. Dong-A ST Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 72. Dong-A ST Sales Value Proportion by Product in 2024

Table 73. Dong-A ST Sales Value Proportion by Application in 2024

Table 74. Dong-A ST Sales Value Proportion by Geographic Area in 2024

Table 75. Dong-A ST Montelukast Sodium Granules SWOT Analysis

Table 76. Dong-A ST Recent Developments

Table 77. Dr. Reddy's Laboratories Corporation Information

Table 78. Dr. Reddy's Laboratories Description and Major Businesses

Table 79. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications

Table 80. Dr. Reddy's Laboratories Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 81. Dr. Reddy's Laboratories Sales Value Proportion by Product in 2024

Table 82. Dr. Reddy's Laboratories Sales Value Proportion by Application in 2024

Table 83. Dr. Reddy's Laboratories Sales Value Proportion by Geographic Area in 2024

Table 84. Dr. Reddy's Laboratories Montelukast Sodium Granules SWOT Analysis

Table 85. Dr. Reddy's Laboratories Recent Developments

Table 86. Pfizer Corporation Information

Table 87. Pfizer Description and Major Businesses

Table 88. Pfizer Product Models, Descriptions and Specifications

Table 89. Pfizer Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 90. Pfizer Sales Value Proportion by Product in 2024

Table 91. Pfizer Sales Value Proportion by Application in 2024

Table 92. Pfizer Sales Value Proportion by Geographic Area in 2024

Table 93. Pfizer Montelukast Sodium Granules SWOT Analysis

Table 94. Pfizer Recent Developments

Table 95. Luye Pharma Group Corporation Information

Table 96. Luye Pharma Group Description and Major Businesses

Table 97. Luye Pharma Group Product Models, Descriptions and Specifications

Table 98. Luye Pharma Group Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 99. Luye Pharma Group Recent Developments

Table 100. Hengrui Medicine Corporation Information

Table 101. Hengrui Medicine Description and Major Businesses

Table 102. Hengrui Medicine Product Models, Descriptions and Specifications

Table 103. Hengrui Medicine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 104. Hengrui Medicine Recent Developments

Table 105. Hybio Pharmaceutical Corporation Information

Table 106. Hybio Pharmaceutical Description and Major Businesses

Table 107. Hybio Pharmaceutical Product Models, Descriptions and Specifications

Table 108. Hybio Pharmaceutical Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 109. Hybio Pharmaceutical Recent Developments

Table 110. Teva Pharmaceutical Industries Corporation Information

Table 111. Teva Pharmaceutical Industries Description and Major Businesses

Table 112. Teva Pharmaceutical Industries Product Models, Descriptions and Specifications

Table 113. Teva Pharmaceutical Industries Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 114. Teva Pharmaceutical Industries Recent Developments

Table 115. Mylan Pharmaceuticals Corporation Information

Table 116. Mylan Pharmaceuticals Description and Major Businesses

Table 117. Mylan Pharmaceuticals Product Models, Descriptions and Specifications

Table 118. Mylan Pharmaceuticals Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)

Table 119. Mylan Pharmaceuticals Recent Developments

Table 120. Key Raw Materials Distribution

Table 121. Raw Materials Key Suppliers

Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 123. Milestones in Production Technology Evolution

Table 124. Distributors List

Table 125. Market Trends and Market Evolution

Table 126. Market Drivers and Opportunities

Table 127. Market Challenges, Risks, and Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Montelukast Sodium Granules Product Picture

Figure 2. Global Montelukast Sodium Granules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. 5mg Product Picture

Figure 4. 10mg Product Picture

Figure 5. Global Montelukast Sodium Granules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Others

Figure 9. Montelukast Sodium Granules Report Years Considered

Figure 10. Global Montelukast Sodium Granules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 12. Global Montelukast Sodium Granules Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Montelukast Sodium Granules Revenue Market Share by Region (2020-2031)

Figure 14. Global Montelukast Sodium Granules Sales (2020-2031) & (kg)

Figure 15. Global Montelukast Sodium Granules Sales (CAGR) by Region (2020-2031) (kg)

Figure 16. Global Montelukast Sodium Granules Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Montelukast Sodium Granules Sales Volume Market Share in 2024

Figure 18. Global Montelukast Sodium Granules Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. 5mg Revenue Market Share by Manufacturer in 2024

Figure 21. 10mg Revenue Market Share by Manufacturer in 2024

Figure 22. Global Montelukast Sodium Granules Sales Market Share by Type (2020-2031)

Figure 23. Global Montelukast Sodium Granules Revenue Market Share by Type (2020-2031)

Figure 24. Global Montelukast Sodium Granules Sales Market Share by Application (2020-2031)

Figure 25. Global Montelukast Sodium Granules Revenue Market Share by Application (2020-2031)

Figure 26. North America Montelukast Sodium Granules Sales YoY (2020-2031) & (kg)

Figure 27. North America Montelukast Sodium Granules Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Montelukast Sodium Granules Sales Revenue (US$ Million) in 2024

Figure 29. North America Montelukast Sodium Granules Sales Volume (kg) by Type (2020- 2031)

Figure 30. North America Montelukast Sodium Granules Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Montelukast Sodium Granules Sales Volume (kg) by Application (2020-2031)

Figure 32. North America Montelukast Sodium Granules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Montelukast Sodium Granules Sales YoY (2020-2031) & (kg)

Figure 37. Europe Montelukast Sodium Granules Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Montelukast Sodium Granules Sales Revenue (US$ Million) in 2024

Figure 39. Europe Montelukast Sodium Granules Sales Volume (kg) by Type (2020-2031)

Figure 40. Europe Montelukast Sodium Granules Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Montelukast Sodium Granules Sales Volume (kg) by Application (2020-2031)

Figure 42. Europe Montelukast Sodium Granules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 44. France Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Montelukast Sodium Granules Sales YoY (2020-2031) & (kg)

Figure 49. Asia-Pacific Montelukast Sodium Granules Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Montelukast Sodium Granules Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Montelukast Sodium Granules Sales Volume (kg) by Type (2020- 2031)

Figure 52. Asia-Pacific Montelukast Sodium Granules Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Montelukast Sodium Granules Sales Volume (kg) by Application (2020-2031)

Figure 54. Asia-Pacific Montelukast Sodium Granules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 59. India Montelukast Sodium Granules Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Montelukast Sodium Granules Sales YoY (2020-2031) & (kg)

Figure 61. Central and South America Montelukast Sodium Granules Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Montelukast Sodium Granules Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Montelukast Sodium Granules Sales Volume (kg) by Type (2021-2031)

Figure 64. Central and South America Montelukast Sodium Granules Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Montelukast Sodium Granules Sales Volume (kg) by Application (2020-2031)

Figure 66. Central and South America Montelukast Sodium Granules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Montelukast Sodium Granules Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Montelukast Sodium Granules Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Montelukast Sodium Granules Sales YoY (2020-2031) & (kg)

Figure 70. Middle East and Africa Montelukast Sodium Granules Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Montelukast Sodium Granules Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Montelukast Sodium Granules Sales Volume (kg) by Type (2021-2031)

Figure 73. South America Montelukast Sodium Granules Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Montelukast Sodium Granules Sales Volume (kg) by Application (2020-2031)

Figure 75. Middle East and Africa Montelukast Sodium Granules Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Montelukast Sodium Granules Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Montelukast Sodium Granules Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Montelukast Sodium Granules Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Montelukast Sodium Granules Revenue (2020-2025) & (US$ Million)

Figure 80. Montelukast Sodium Granules Industry Chain Mapping

Figure 81. Regional Montelukast Sodium Granules Manufacturing Base Distribution (%)

Figure 82. Global Montelukast Sodium Granules Production Market Share by Region (2020-2031)

Figure 83. Montelukast Sodium Granules Production Process

Figure 84. Regional Montelukast Sodium Granules Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Montelukast Sodium Granules Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-24X17944

Global Montelukast Sodium Granules Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Montelukast Sodium Granules Market

Report Includes:

Scope of Montelukast Sodium Granules Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Montelukast Sodium Granules Market report?

What are the Application segmentation covered in the Montelukast Sodium Granules Market report?

What are the Type segmentation covered in the Montelukast Sodium Granules Market report?

FEATURED COMPANIES

RELATED REPORTS